- Home
- RAND vs CCEL Comparison
RAND vs CCEL Comparison
Compare RAND & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- CCEL
- Stock Information
- Founded
- RAND 1969
- CCEL 1989
- Country
- RAND United States
- CCEL United States
- Employees
- RAND N/A
- CCEL N/A
- Industry
- RAND Finance: Consumer Services
- CCEL Managed Health Care
- Sector
- RAND Finance
- CCEL Health Care
- Exchange
- RAND Nasdaq
- CCEL Nasdaq
- Market Cap
- RAND 47.5M
- CCEL 53.9M
- IPO Year
- RAND N/A
- CCEL 1997
- Fundamental
- Price
- RAND $16.89
- CCEL $6.36
- Analyst Decision
- RAND
- CCEL
- Analyst Count
- RAND 0
- CCEL 0
- Target Price
- RAND N/A
- CCEL N/A
- AVG Volume (30 Days)
- RAND 2.8K
- CCEL 3.4K
- Earning Date
- RAND 11-04-2024
- CCEL 10-18-2024
- Dividend Yield
- RAND 6.87%
- CCEL N/A
- EPS Growth
- RAND 72.67
- CCEL N/A
- EPS
- RAND 4.19
- CCEL N/A
- Revenue
- RAND $7,874,601.00
- CCEL $31,641,636.00
- Revenue This Year
- RAND N/A
- CCEL $3.70
- Revenue Next Year
- RAND N/A
- CCEL $10.57
- P/E Ratio
- RAND $4.03
- CCEL N/A
- Revenue Growth
- RAND 13.24
- CCEL 1.93
- 52 Week Low
- RAND $12.50
- CCEL $3.67
- 52 Week High
- RAND $19.60
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- RAND 48.63
- CCEL 47.46
- Support Level
- RAND $16.42
- CCEL $6.16
- Resistance Level
- RAND $17.16
- CCEL $7.19
- Average True Range (ATR)
- RAND 0.41
- CCEL 0.30
- MACD
- RAND 0.05
- CCEL 0.02
- Stochastic Oscillator
- RAND 64.88
- CCEL 19.53
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.